← Back to Search

AMP Mobility Program for Hospitalized Patients with Immobility (AMP SWT Trial)

N/A
Waitlist Available
Led By Erik Hoyer, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Analysis will only include those with lengths of stay >=3 days
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 39 months
Awards & highlights

AMP SWT Trial Summary

This trial will test the effects of a new hospital-wide mobility program on patients' outcomes. The program includes early mobilization for even the sickest patients. The results of this project will help inform hospitals nationwide on the effectiveness of the program.

Who is the study for?
This trial is for adult patients hospitalized with a stay of at least 3 days, who may experience loss of physical function due to immobility. It's not open to those under 18 or patients with an active do-not-resuscitate (DNR) order.Check my eligibility
What is being tested?
The trial is testing the AMP program, aimed at improving mobility and preventing functional loss in hospitalized adults. The study will assess its impact on clinical outcomes and identify factors that affect the adoption of this mobility program.See study design
What are the potential side effects?
Since this intervention focuses on patient mobilization rather than medication, side effects are not typical as with drug trials but may include fatigue or discomfort from increased activity.

AMP SWT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hospital stay was 3 days or longer.

AMP SWT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~39 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 39 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
% of patients meeting daily mobility goal
% of patients receiving physical and/or occupational therapy consults
% of patients with mobility measurements documented daily
Secondary outcome measures
Discharge disposition status
Employee injuries resulting from patient mobilization
Hospital length of stay (days)
+3 more

AMP SWT Trial Design

1Treatment groups
Experimental Treatment
Group I: AMP ImplementationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,266 Previous Clinical Trials
14,820,821 Total Patients Enrolled
Erik Hoyer, PhDPrincipal InvestigatorJohns Hopkins University
Sapna Kudchadkar, MDPrincipal InvestigatorJohns Hopkins University

Media Library

AMP Implementation Clinical Trial Eligibility Overview. Trial Name: NCT05021679 — N/A
Immobility Research Study Groups: AMP Implementation
Immobility Clinical Trial 2023: AMP Implementation Highlights & Side Effects. Trial Name: NCT05021679 — N/A
AMP Implementation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05021679 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What conclusions is the trial attempting to reach?

"The primary measure of success for this trial, which will be assessed across a 39 month period, is the percentage of patients with daily mobility records. Other relevant outcome metrics include number of physical and occupational therapy visits logged on an electronic medical record; hospital-acquired morbidities such as falls, pressure injuries or venous thromboembolism captured from EMRs; and finally patient discharge disposition status determined through extraction from their respective digital health profiles."

Answered by AI

Are there any opportunities to participate in this medical experiment at present?

"Per the clinicaltrials.gov data, this medical study is not presently looking for patients. This research was initially posted on January 1st 2021 and was most recently updated two months ago. Despite this trial being inactive, 8 other studies are currently recruiting participants as of now."

Answered by AI
~3848 spots leftby May 2025